Daptomycin failure in a neutropenic leukemia patient with staphylococcous aureus meningitis

Leukemia and Lymphoma

Volumn 53, Issue 8, 2012, Pages 1610-1612

  Wahby, Krista A ^a   Alangaden, George J ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; DAPTOMYCIN; GENTAMICIN; HYPERTENSIVE AGENT; LINEZOLID; RIFAMPICIN; VANCOMYCIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; CASE REPORT; CATHETER INFECTION; CEREBROSPINAL FLUID ANALYSIS; CHRONIC KIDNEY DISEASE; COMATOSE PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HUMAN CELL; LETTER; LUMBAR PUNCTURE; MALE; MENINGITIS; MENTAL HEALTH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEUTROPENIA; PRIORITY JOURNAL; SEPTIC SHOCK; THROMBOCYTE TRANSFUSION; TREATMENT FAILURE; VITAL SIGN;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; HUMANS; LEUKEMIA; MALE; MENINGITIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NEUTROPENIA; RENAL INSUFFICIENCY, CHRONIC; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84864238242     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.661051     Document Type: Letter

References (16)

1. Steenbergen JN, Alder J, Th orne GM, et a l. Daptomycin: alipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother 2005;55:283-288.
2. C UBICIN [package insert]. Lexington, MA: Cubist Pharmaceuticals, Inc.; August 2008.
3. L odise TP, Graves J, Evans A, et al. Relationship between vancomycin MIC and failure among patients with methicillinresistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008;52:3315-3320.
4. Holmes NA, Turnidge JD, Munckhof WJ, et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycn minimum inhibitory concentrations. J Infect Dis 2011;204:340-347.
5. Lortholory O, Lefort A, Tod M, et al. Pharmacodynamics andpharmacokinetics of antibacterial drugs in the management of febrile neutropenia. Lancet 2008;8:612-620.
6. Zeitlinger MA, Derendorf H, Mouton JW, et al. Protein binding: do we ever learn? Antimicrob Agents Chemother 2011;55:3067-3074.
7. DeRyke CA, Sutherland C, Zhang B, et a l. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Entero coccusspecies. Antimicrob Agents Chemother 2006;50:3529-3534.
8. Lee DH, Palermo B, Chowdhury M. Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin. Clin Infect Dis 2008;47:588-590.
9. Kullar R, Chin JN, Parker D, et al. Pharmacokinetics of single-dose daptomycin in patients with suspected or confi rmed neurologicalinfections. Antimicrob Agents Chemother 2011;55:3505-3509.
10. G oedecke VA, Clajus C, Burkhardt O, et a l. Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient. Scan J Infect Dis 2009;41:155-157.
11. Sader HS, Jones RN. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007 - 2008). Diagn Microbiol Infect Dis 2009;65:158-162.
12. L e J, Bookstaver PB, Rudisill CN. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high dose and combination daptomycin therapy. Ann Pharmacother 2010;44: 2001-2006.
13. G erber P, Stucki A, Acosta F, et a l. Daptomycin is more effi cacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 2006;57: 720-723.
14. S afdar N, Andes D, Craig WA. In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother 2004;48:63-68.
15. Pankey G, Ashcraft D, Patel N. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid andvancomycin. Antimicrob Agents Chemother 2005;49:5166-5168.
16. R and KH, Houch H. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. J Antimicrob Chemother 2004;53:530-532.